StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
20
Publishing Date
2023 - 12 - 01
1
2023 - 10 - 27
1
2023 - 10 - 10
1
2023 - 09 - 06
1
2023 - 05 - 23
1
2023 - 05 - 08
1
2023 - 01 - 05
1
2022 - 10 - 12
1
2022 - 09 - 29
1
2022 - 09 - 02
1
2022 - 05 - 18
2
2022 - 04 - 25
1
2022 - 04 - 15
1
2021 - 10 - 25
1
2021 - 09 - 30
1
2021 - 08 - 23
1
2021 - 06 - 04
1
2021 - 05 - 17
1
2021 - 04 - 13
1
Sector
Health technology
20
Manufacturing
2
N/a
1
Tags
Acne
11
Acquisition
3
Aesthetic
14
America
17
Application
4
Approval
8
Biocanada
42
Cancer
4
Care
6
Ces
4
Clinical-trials-phase-iii
4
Companies
26
Conference
11
Corporation
8
Covid
3
Deadline
24
Device
11
Disease
20
Drug
22
Earnings
14
Energy
7
Events
14
Expected
8
Eye
16
Fda
5
Financial results
4
Gastrointestinal
5
Global
36
Growing
12
Growth
63
Health
82
Injection
4
Ipo
5
Laser
9
Liver
7
Macular
8
Market
106
Meeting
4
Money
5
N/a
279
Offering
4
Patent
4
People
6
Pharma
4
Pharmaceuticals
7
Phase 3
6
Presentation
4
Program
4
Psoriasis
4
Report
28
Research
33
Results
31
Risk
6
Set
4
Skin
7
Study
4
Therapeutics
13
Treatment
35
Trial
11
Xipere
4
Entities
4d molecular therapeutics inc
14
Abbott laboratories
67
Abbvie inc.
65
Ac immune sa
21
Acumen pharmaceuticals inc
14
Aldeyra therapeutics, inc.
17
Alnylam pharmaceuticals, inc.
13
Alterity therapeutics limited
14
Amgen inc.
26
Amicus therapeutics, inc.
20
Anavex life sciences corp.
24
Annovis bio, inc.
29
Astellas pharma inc
16
Astrazeneca plc
34
Athira pharma, inc.
24
Bausch health companies inc.
20
Beam therapeutics inc.
15
Becton, dickinson and company
24
Bio-rad laboratories, inc.
16
Biogen inc.
74
Biovie inc.
32
Boston scientific corporation
16
Bridgebio pharma, inc.
15
Bristol-myers squibb company
22
Cassava sciences, inc.
26
Centogene n.v.
23
Cognition therapeutics inc
21
Cyclo therapeutics inc - class a
19
Danaher corporation
18
Denali therapeutics inc.
15
Eli lilly and company
89
Gain therapeutics inc
20
Gilead sciences, inc.
20
Glaxosmithkline plc
39
Global blood therapeutics, inc.
33
Horizon therapeutics public limited company
23
Incyte corporation
16
Inmune bio inc.
16
Ionis pharmaceuticals, inc.
14
Jaguar health, inc.
14
Johnson & johnson
107
Koninklijke philips n.v.
15
Medtronic plc
30
Mesoblast limited
24
Novartis ag
76
Novo nordisk a/s
18
Orange
21
Pfizer, inc.
28
Protalix biotherapeutics, inc.
14
Regeneron pharmaceuticals, inc.
16
Regulus therapeutics inc.
23
Sanofi
179
Sutro biopharma, inc.
14
Takeda pharmaceutical company limited
33
Teva pharmaceutical industries ltd
36
Thermo fisher scientific inc
47
Vaxcyte, inc.
14
Vertex pharmaceuticals incorporated
17
Viatris inc.
16
Zyversa therapeutics inc
18
Symbols
ABBV
6
ABT
1
ACAD
1
AERI
1
ALC
1
ALDX
1
ALPMF
1
ALPMY
1
AMGN
1
ARVL
1
AZN
1
AZNCF
1
BCLI
2
BHC
20
BIIB
2
BSX
1
ENDP
1
GKOS
1
GLAXF
4
GRFS
1
GSK
4
JNJ
5
LLY
1
MNK
1
MNKKQ
1
NBIX
1
NMRD
1
NVS
9
NVSEF
8
OCUL
1
PFE
1
PRGO
1
SGMO
1
SNY
5
SNYNF
4
TAK
1
TARO
1
TEVA
1
TEVJF
4
TKPHF
1
VTRS
4
Exchanges
Nasdaq
11
Nyse
20
Crawled Date
2023 - 12 - 01
1
2023 - 10 - 27
1
2023 - 10 - 10
1
2023 - 09 - 07
1
2023 - 05 - 23
1
2023 - 05 - 08
1
2023 - 01 - 05
1
2022 - 10 - 12
1
2022 - 09 - 29
1
2022 - 09 - 02
1
2022 - 05 - 18
2
2022 - 04 - 25
1
2022 - 04 - 15
1
2021 - 10 - 25
1
2021 - 09 - 30
1
2021 - 08 - 23
1
2021 - 06 - 04
1
2021 - 05 - 17
1
2021 - 04 - 13
1
Crawled Time
00:00
1
01:00
1
03:00
1
07:00
1
11:00
1
12:00
4
12:20
2
13:00
2
13:30
1
14:00
1
15:00
1
18:00
1
19:00
1
20:00
1
21:00
1
Source
www.biospace.com
6
www.prnewswire.com
14
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Disease
entities :
Bausch health companies inc.
save search
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published:
2023-12-01
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
BCLI
A
|
$0.5384
4.69%
4.48%
1M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
disease
companies
health
therapeutics
market
Technological Advancements and Research Efforts Propel Neuromuscular Disease Therapeutics Market Growth
Published:
2023-10-27
(Crawled : 01:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-11.93%
|
O:
-18.18%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-1.63%
|
O:
-3.68%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
23.69%
|
O:
0.0%
H:
0.17%
C:
-2.45%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.29%
|
O:
-0.23%
H:
0.08%
C:
-1.92%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
29.87%
|
O:
-0.59%
H:
0.15%
C:
-1.79%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.36%
|
O:
-15.73%
H:
0.0%
C:
0.0%
BCLI
A
|
$0.5384
4.69%
4.48%
1M
|
Health Technology
|
216.77%
|
O:
3.73%
H:
1.8%
C:
-4.19%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-19.05%
|
O:
-0.45%
H:
0.12%
C:
-2.28%
propel
disease
research
therapeutics
growth
market
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
Published:
2023-10-10
(Crawled : 13:30)
- biospace.com/
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
14.25%
|
O:
1.18%
H:
1.81%
C:
0.52%
liver
disease
report
health
pharmaceuticals
trends
Global Huntington's Disease Treatment Market Analysis Report 2023-2030: Novel Approaches, Regional Trends, and Research Endeavors
Published:
2023-09-06
(Crawled : 00:00)
- prnewswire.com
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
4.55%
|
O:
-0.96%
H:
1.93%
C:
1.69%
SGMO
|
$0.5143
6.02%
5.68%
1M
|
Health Technology
|
-48.0%
|
O:
0.0%
H:
3.0%
C:
-4.77%
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
20.93%
|
O:
0.44%
H:
0.23%
C:
-1.97%
disease
report
treatment
research
global
market
DelveInsight Evaluates a Robust Dry Eye Disease Clinical Trial Pipeline as 60+ Influential Pharma Players to Set Foot in the Domain
Published:
2023-05-23
(Crawled : 15:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
10.85%
|
O:
-1.22%
H:
0.0%
C:
-0.62%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.6%
|
O:
0.74%
H:
0.0%
C:
-1.22%
GKOS
|
$96.5
1.44%
0.0%
700K
|
Health Technology
|
63.39%
|
O:
-0.71%
H:
2.06%
C:
-1.05%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-0.68%
|
O:
-2.27%
H:
4.24%
C:
-2.21%
ALC
|
$79.55
1.38%
-0.25%
1.1M
|
Health Technology
|
-2.58%
|
O:
-0.51%
H:
0.02%
C:
-3.25%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
13.98%
|
O:
-0.31%
H:
0.26%
C:
-1.34%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-16.26%
|
O:
-0.01%
H:
0.0%
C:
0.0%
OCUL
|
$5.22
-10.92%
-12.26%
9.1M
|
Health Technology
|
15.21%
|
O:
4.45%
H:
7.65%
C:
2.21%
GRFS
|
News
|
$6.29
-3.82%
-3.97%
1.2M
|
Health Technology
|
-27.41%
|
O:
0.78%
H:
0.0%
C:
-3.74%
ALDX
|
$3.865
-2.89%
-2.98%
430K
|
Health Technology
|
-59.22%
|
O:
0.0%
H:
2.36%
C:
0.61%
pharma
disease
pipeline
set
eye
trial
Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023
Published:
2023-05-08
(Crawled : 12:20)
- biospace.com/
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
49.91%
|
O:
0.94%
H:
2.55%
C:
1.78%
disease
presentation
pharmaceuticals
Insights on the Allergic Conjunctivitis Global Market to 2031 - by Drug Class, Disease Type, Distribution Channel and Region
Published:
2023-01-05
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.58%
|
O:
0.04%
H:
0.0%
C:
-1.84%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.51%
|
O:
0.35%
H:
1.43%
C:
1.28%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-18.93%
|
O:
0.74%
H:
0.44%
C:
0.07%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
22.07%
|
O:
0.84%
H:
4.71%
C:
3.46%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
1.02%
|
O:
0.83%
H:
1.98%
C:
1.04%
drug
global
disease
distribution
market
SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION
Published:
2022-10-12
(Crawled : 12:20)
- prnewswire.com
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
32.22%
|
O:
-0.3%
H:
2.58%
C:
2.12%
pharmaceuticals
liver
trends
disease
report
growing
health
USD 45.37 Mn incremental growth expected in Darier Disease Drugs Market -- Driven by an increase in demand for advanced dermatological diagnosis
Published:
2022-09-29
(Crawled : 03:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
33.95%
|
O:
-3.32%
H:
4.73%
C:
4.73%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
51.07%
|
O:
1.87%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
27.38%
|
O:
-1.26%
H:
0.7%
C:
-0.23%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
21.96%
|
O:
0.17%
H:
1.1%
C:
0.16%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
34.42%
|
O:
-0.14%
H:
0.53%
C:
-0.2%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
17.0%
|
O:
-1.2%
H:
0.0%
C:
-5.83%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
14.22%
|
O:
0.17%
H:
0.28%
C:
-1.47%
disease
expected
dermatological
growth
market
8 MM Ulcerative Colitis Market Forecasts, Epidemiology & Pipeline Analysis 2022-2027: Novel Emerging Drugs will Shift the Inflammatory Bowel Disease (IBD) Treatment Paradigm
Published:
2022-09-02
(Crawled : 18:00)
- prnewswire.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-47.61%
|
O:
1.43%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-4.29%
|
O:
-0.15%
H:
0.29%
C:
-1.02%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-45.49%
|
O:
0.24%
H:
0.13%
C:
-2.23%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
15.87%
|
O:
0.21%
H:
0.86%
C:
-0.99%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-10.34%
|
O:
2.55%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
142.87%
|
O:
0.32%
H:
0.04%
C:
-2.83%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
32.63%
|
O:
1.06%
H:
1.35%
C:
-3.15%
treatment
disease
market
ulcerative colitis
Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022
Published:
2022-05-18
(Crawled : 13:00)
- biospace.com/
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-20.9%
|
O:
-0.72%
H:
1.09%
C:
-9.3%
week
disease
Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
Published:
2022-05-18
(Crawled : 07:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
5.63%
|
O:
-0.31%
H:
0.53%
C:
-0.19%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-11.15%
|
O:
-0.43%
H:
0.0%
C:
0.0%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-20.9%
|
O:
-0.72%
H:
1.09%
C:
-9.3%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
6.52%
|
O:
-0.17%
H:
0.59%
C:
-1.52%
ACAD
|
$16.82
-1.47%
-1.49%
3.5M
|
Health Technology
|
0.17%
|
O:
-3.61%
H:
1.39%
C:
-3.14%
europe
disease
growth
market
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026
Published:
2022-04-25
(Crawled : 12:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-39.47%
|
O:
-2.78%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-26.31%
|
O:
-0.99%
H:
0.0%
C:
-0.11%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-15.25%
|
O:
0.27%
H:
0.0%
C:
0.0%
MNKKQ
|
$0.02
|
Manufacturing
|
-81.52%
|
O:
-2.96%
H:
2.29%
C:
-6.57%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-41.26%
|
O:
-0.1%
H:
0.35%
C:
-0.09%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
4.12%
|
O:
-5.01%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.91%
|
O:
-0.67%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-20.61%
|
O:
0.01%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-12.45%
|
O:
-1.57%
H:
1.5%
C:
1.39%
BSX
|
$67.33
-0.13%
-0.31%
7M
|
Health Technology
|
46.44%
|
O:
-4.95%
H:
2.32%
C:
1.9%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-60.51%
|
O:
-3.12%
H:
0.37%
C:
0.19%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
4.85%
|
O:
-2.17%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-17.48%
|
O:
-2.01%
H:
0.0%
C:
0.0%
NMRD
|
$0.0798
-28.78%
28K
|
Health Technology
|
-97.57%
|
O:
17.02%
H:
0.52%
C:
-2.6%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
4.09%
|
O:
-1.38%
H:
0.65%
C:
0.46%
device
disease
Gastrointestinal Diseases Therapeutics Market to record USD 22.82 Bn growth | Evolving Opportunities with Abbott Laboratories and AbbVie Inc. | Technavio
Published:
2022-04-15
(Crawled : 11:00)
- prnewswire.com
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
gastrointestinal
therapeutics
growth
market
disease
New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients, A Cause Of Morbidity And Mortality Projected To Grow In The United States
Published:
2021-10-25
(Crawled : 12:00)
- prnewswire.com
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-69.52%
|
O:
0.28%
H:
1.95%
C:
0.9%
disease
liver disease
liver
Bausch + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial Of NOV03 (perfluorohexyloctane) in Dry Eye Disease Associated with Meibomian Gland Dysfunction
Published:
2021-09-30
(Crawled : 12:00)
- biospace.com/
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-68.94%
|
O:
-0.39%
H:
0.61%
C:
-0.64%
dry eye
disease
eye
eye disease
results
topline
phase 3
trial
Rise in Prevalence of Dry Eye Disease Due to Ageing, Use of Computers to Drive Dry Eye Disease Treatment Market, Says TMR
Published:
2021-08-23
(Crawled : 14:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-0.27%
|
O:
0.57%
H:
0.42%
C:
-0.12%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-19.0%
|
O:
-0.31%
H:
0.3%
C:
-0.44%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-68.74%
|
O:
1.07%
H:
0.6%
C:
-0.11%
dry eye
disease
treatment
eye
eye disease
Global Generic Drugs Market Report 2021: Market to Surpass $750 Billion by 2030 - Patent Expiration of Blockbuster Drugs & Growing Prevalence of Acute and Chronic Diseases
Published:
2021-06-04
(Crawled : 21:00)
- prnewswire.com
ENDP
|
$0.2926
-9.6%
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
TARO
|
$42.25
0.14%
0.0%
17K
|
Health Technology
|
Email alert
Add to watchlist
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
disease
growing
drug
patent
Salix Will Feature New Data At Digestive Disease Week® 2021
Published:
2021-05-17
(Crawled : 12:00)
- biospace.com/
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-69.93%
|
O:
-0.14%
H:
0.83%
C:
0.76%
disease
Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction
Published:
2021-04-13
(Crawled : 13:00)
- biospace.com/
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-70.82%
|
O:
0.03%
H:
0.17%
C:
-0.5%
dry eye
disease
eye
eye disease
results
topline
phase 3
trial
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.